LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants - Westendorf, Kathryn; Žentelis, Stefanie; Wang, Lingshu; Foster, Denisa; Vaillancourt, Peter; Wiggin, Matthew; Lovett, Erica; van der Lee, Robin; Hendle, Jörg; Pustilnik, Anna; Sauder, J. Michael; Kraft, Lucas; et al. (Cell reports (Cambridge), 2022)
Keywords: Antibodies, Monoclonal - chemistry; Antibodies, Monoclonal - pharmacology; Antibodies, Monoclonal - therapeutic use; Antibodies, Neutralizing - chemistry; Antibodies, Neutralizing - pharmacology; Antibodies, Neutralizing - therapeutic use; Antibodies, Viral; COVID-19; COVID-19 Drug Treatment; CP: Microbiology; Epitopes; Humans; neutralizing antibody; SARS-CoV-2; variant of concern; COVID-19; neutralizing antibody; variant of concern; SARS-CoV-2; CP: Microbiology